{"transactions":[{"id":4636091,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-06T20:18:26.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":4202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"4,202 shares will vest on October 2, 2027. 4,203 shares will vest on October 2, 2028."}],"balance_after":8405,"derivative":{"exercise_price":154.96,"expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":4202},"source":{"system":"sec-edgar","filing":"0001628280-26-065238","document":"wk-form4_1791317904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026065238/wk-form4_1791317904.xml","form_type":"4"}},{"id":4636090,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:18:26.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":4202,"price":190,"value":798380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":45788,"source":{"system":"sec-edgar","filing":"0001628280-26-065238","document":"wk-form4_1791317904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026065238/wk-form4_1791317904.xml","form_type":"4"}},{"id":4636089,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:18:26.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":4202,"price":154.96,"value":651141.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":49990,"source":{"system":"sec-edgar","filing":"0001628280-26-065238","document":"wk-form4_1791317904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026065238/wk-form4_1791317904.xml","form_type":"4"}},{"id":4636088,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-06T20:18:26.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":1333,"price":178.75,"value":238273.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":45788,"source":{"system":"sec-edgar","filing":"0001628280-26-065238","document":"wk-form4_1791317904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026065238/wk-form4_1791317904.xml","form_type":"4"}},{"id":4629612,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-10-05T20:01:21.000Z","date":"2026-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1248,"price":181.7,"value":226761.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":47121,"source":{"system":"sec-edgar","filing":"0001628280-26-064889","document":"wk-form4_1791230479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026064889/wk-form4_1791230479.xml","form_type":"4"}},{"id":4626922,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":false,"shares":4542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"4,542 shares will vest on March 1, 2027, and 4,543 shares will vest on March 1, 2028."}],"balance_after":9085,"derivative":{"exercise_price":155.38,"expiration_date":"2035-03-01","underlying":"Common Stock","underlying_shares":4542},"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626921,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":false,"shares":8404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"4,202 shares will vest on each of October 2, 2026, and October 2, 2027. 4,203 shares will vest on October 2, 2028."}],"balance_after":12607,"derivative":{"exercise_price":154.96,"expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":8404},"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626920,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":4542,"price":190,"value":862980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":48369,"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626919,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":true,"shares":4542,"price":155.38,"value":705735.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":52911,"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626918,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":8404,"price":190,"value":1596760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":48369,"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4626917,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-25T20:09:43.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":true,"shares":8404,"price":154.96,"value":1302283.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":56773,"source":{"system":"sec-edgar","filing":"0001628280-26-063572","document":"wk-form4_1790366980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063572/wk-form4_1790366980.xml","form_type":"4"}},{"id":4624549,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-22T20:07:23.000Z","date":"2026-09-21","kind":"exercise","planned":true,"acquired":false,"shares":5426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":5426,"derivative":{"exercise_price":141.79,"exercise_date":"2027-09-03","expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":5426},"source":{"system":"sec-edgar","filing":"0001628280-26-063026","document":"wk-form4_1790107640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063026/wk-form4_1790107640.xml","form_type":"4"}},{"id":4624548,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-22T20:07:23.000Z","date":"2026-09-21","kind":"sale","planned":true,"acquired":false,"shares":5426,"price":180,"value":976680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":48369,"source":{"system":"sec-edgar","filing":"0001628280-26-063026","document":"wk-form4_1790107640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063026/wk-form4_1790107640.xml","form_type":"4"}},{"id":4624547,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-22T20:07:23.000Z","date":"2026-09-21","kind":"exercise","planned":true,"acquired":true,"shares":5426,"price":141.79,"value":769352.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":53795,"source":{"system":"sec-edgar","filing":"0001628280-26-063026","document":"wk-form4_1790107640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026063026/wk-form4_1790107640.xml","form_type":"4"}},{"id":3517271,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:13:40.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":3035,"price":165.9,"value":503506.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":48369,"source":{"system":"sec-edgar","filing":"0001628280-26-060911","document":"wk-form4_1788898417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026060911/wk-form4_1788898417.xml","form_type":"4"}},{"id":3517270,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-08T20:13:40.000Z","date":"2026-09-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":2842,"price":169.61,"value":482031.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":51404,"source":{"system":"sec-edgar","filing":"0001628280-26-060911","document":"wk-form4_1788898417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1995525/000162828026060911/wk-form4_1788898417.xml","form_type":"4"}},{"id":679438,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-21T20:06:30.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":false,"shares":5426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"5,426 shares will vest on each of September 3, 2026, and September 3, 2027."}],"balance_after":10852,"derivative":{"exercise_price":141.79,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":5426},"source":{"system":"sec-edgar","filing":"0001628280-26-058417","document":"wk-form4_1787342788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/730272/000162828026058417/wk-form4_1787342788.xml","form_type":"4"}},{"id":679437,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-21T20:06:30.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":5426,"price":180,"value":976680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":54246,"source":{"system":"sec-edgar","filing":"0001628280-26-058417","document":"wk-form4_1787342788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000162828026058417/wk-form4_1787342788.xml","form_type":"4"}},{"id":679436,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-21T20:06:30.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":5426,"price":141.79,"value":769352.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025."}],"balance_after":59672,"source":{"system":"sec-edgar","filing":"0001628280-26-058417","document":"wk-form4_1787342788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000162828026058417/wk-form4_1787342788.xml","form_type":"4"}},{"id":803401,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-22T17:26:04.000Z","date":"2026-04-21","kind":"sale","planned":true,"acquired":false,"shares":3832,"price":140,"value":536480.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on August 19th, 2025."}],"balance_after":54246,"source":{"system":"sec-edgar","filing":"0001193125-26-169682","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526169682/ownership.xml","form_type":"4"}},{"id":831656,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-23T15:53:49.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":25890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the stock options will vest and become exercisable annually on March 5, 2027, March 5, 2028, and March 5, 2029."}],"balance_after":25890,"derivative":{"exercise_price":141.91,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":25890},"source":{"system":"sec-edgar","filing":"0001193125-26-119036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119036/ownership.xml","form_type":"4"}},{"id":831655,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-23T15:53:49.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":24134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Loeillot was awarded 24,134 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":58078,"source":{"system":"sec-edgar","filing":"0001193125-26-119036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526119036/ownership.xml","form_type":"4"}},{"id":872218,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:39:26.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1610,"price":124.97,"value":201201.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":33944,"source":{"system":"sec-edgar","filing":"0001193125-26-087595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087595/ownership.xml","form_type":"4"}},{"id":872217,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-03T18:39:26.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":344,"price":128.73,"value":44283.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":35554,"source":{"system":"sec-edgar","filing":"0001193125-26-087595","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312526087595/ownership.xml","form_type":"4"}},{"id":988078,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-26T21:30:04.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":7041,"price":170,"value":1196970.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 12, 2024."}],"balance_after":35898,"source":{"system":"sec-edgar","filing":"0001193125-25-300642","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525300642/ownership.xml","form_type":"4"}},{"id":1023791,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-06T14:59:45.000Z","date":"2025-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1248,"price":145.23,"value":181247.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":42939,"source":{"system":"sec-edgar","filing":"0001193125-25-231365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525231365/ownership.xml","form_type":"4"}},{"id":1048885,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-04T14:55:53.000Z","date":"2025-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2506,"price":116.18,"value":291147.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":44187,"source":{"system":"sec-edgar","filing":"0001193125-25-195655","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000119312525195655/ownership.xml","form_type":"4"}},{"id":1233639,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T18:18:32.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":13627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028."}],"balance_after":13627,"derivative":{"exercise_price":155.38,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":13627},"source":{"system":"sec-edgar","filing":"0000950170-25-031547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017025031547/ownership.xml","form_type":"4"}},{"id":1233638,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-04T18:18:32.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":14480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Loeillot was awarded 14,480 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":46693,"source":{"system":"sec-edgar","filing":"0000950170-25-031547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017025031547/ownership.xml","form_type":"4"}},{"id":1239824,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-28T21:30:38.000Z","date":"2025-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":343,"price":156.54,"value":53693.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of performance stock units."}],"balance_after":32213,"source":{"system":"sec-edgar","filing":"0000950170-25-030080","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017025030080/ownership.xml","form_type":"4"}},{"id":1356563,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-21T18:32:09.000Z","date":"2024-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":861,"price":123.41,"value":106256.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units."}],"balance_after":32556,"source":{"system":"sec-edgar","filing":"0000950170-24-129622","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024129622/ownership.xml","form_type":"4"}},{"id":1417028,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-05T00:41:20.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":16278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the stock options will vest and become exercisable annually on September 3, 2025, September 3, 2026, and September 3, 2027."}],"balance_after":16278,"derivative":{"exercise_price":141.79,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":16278},"source":{"system":"sec-edgar","filing":"0000950170-24-103643","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024103643/ownership.xml","form_type":"4"}},{"id":1417027,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-09-05T00:41:20.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":17631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Loeillot was awarded 17,631 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":33417,"source":{"system":"sec-edgar","filing":"0000950170-24-103643","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024103643/ownership.xml","form_type":"4"}},{"id":1611325,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-01T00:07:56.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":2860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the stock options will vest and become exercisable annually on February 27, 2025, February 27, 2026 and February 27, 2027."}],"balance_after":2860,"derivative":{"exercise_price":192.71,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":2860},"source":{"system":"sec-edgar","filing":"0000950170-24-023416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024023416/ownership.xml","form_type":"4"}},{"id":1611324,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2024-03-01T00:07:56.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":2880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Loeillot was awarded 2,880 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":15786,"source":{"system":"sec-edgar","filing":"0000950170-24-023416","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017024023416/ownership.xml","form_type":"4"}},{"id":1769528,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CCO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T00:44:09.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":24236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal annual installments over a five-year period with each such vesting date occurring on the anniversary of the grant date."}],"balance_after":24236,"derivative":{"exercise_price":154.96,"expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":24236},"source":{"system":"sec-edgar","filing":"0000950170-23-051753","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017023051753/ownership.xml","form_type":"4"}},{"id":1769527,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":21079,"kind":"person","name":"Loeillot Olivier","position":1,"cik":"0001995525","reported_name":"Loeillot Olivier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CCO"}}],"security":"Common Stock","published_at":"2023-10-04T00:44:09.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":12906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Loeillot was awarded 12,906 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal installments over a five-year period with each such vesting date occurring on the anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":12906,"source":{"system":"sec-edgar","filing":"0000950170-23-051753","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000095017023051753/ownership.xml","form_type":"4"}}]}